Leukaemia

Original Editor - Lucinda hampton

Top Contributors - Lucinda hampton, Uchechukwu Chukwuemeka, Kim Jackson, Vidya Acharya, Kapil Narale and Aya Alhindi

Introduction

3D Medical Animation still shows an increase in the white blood cells of a person suffering from Leukaemia.

Leukaemia is a cancer of the early blood-forming cells.

• Most often, leukaemia is a cancer of the white blood cells, but some leukaemias start in other blood cell types.
• There are several types of leukaemia, which are divided based mainly on whether the leukaemia is acute (fast-growing) or chronic (slower-growing), and whether it starts in myeloid cells or lymphoid cells.
• Different types of leukaemia have different treatment options and outlooks.  .
• Leukaemia is hundreds of different diseases on a molecular level, with no two leukaemias being exactly alike.

Pathophysiology

Bone marrow is responsible for making red blood cells (RBC), white blood cells (WBC), and platelets.

In leukaemia, due to the immature cells or some defect in the cells of the bone marrow, abnormal and functionless WBCs are produced which are unable to fight against the infection and defend the body against foreign substances. Also, they obstruct the production of other blood cells by dividing quickly and crowding among normal cells.

Myelogenous vs. Lymphocytic Leukaemia

All of the blood cells are derived from pluripotential stem cells in the bone marrow thanks to a process called hematopoiesis. These cells differentiate into either:

1. Myeloid cells (the myeloid cell line): Which differentiate into red blood cells, platelets, and the type of cells found in myeloid leukaemia: neutrophils, monocytes, and more.
2. Lymphoid cells: Which differentiate into either B lymphocytes (B cells) or T lymphocytes (T cells).lymphocytic leukaemias may begin in either of these cell types.

Acute leukaemia vs. Chronic leukaemia

1. Acute leukaemia: arises from immature cells in the bone marrow (myeloblasts or lymphoblasts). These cells do not function like fully mature ones in fighting off infections. In addition, they often crowd the bone marrow, preventing the production of other blood cells such as red blood cells, other white blood cells, and platelets. Without treatment, acute leukaemias often progress very rapidly.
2. Chronic leukaemia: arises from mature, but abnormal white blood cells. These cancers grow much more slowly and may be discovered accidentally when a blood count is done for another reason.

Types

The major types of leukaemia are:

1. Acute lymphocytic leukaemia (ALL): This is the most common type of leukaemia in young children. It can also occur in adults.
2. Acute myelogenous leukaemia (AML): The most common type of acute leukaemia in adults. It occurs in children and adults.
3. Chronic lymphocytic leukaemia (CLL): The most common chronic adult leukaemia, you may feel well for years without needing treatment.
4. Chronic myelogenous leukaemia (CML). This type of leukaemia mainly affects adults. A person with CML may have few or no symptoms for months or years before entering a phase where the leukaemia cells grow more quickly.

• Other types: Other, rarer types of leukaemia exist, including hairy cell leukaemia, myelodysplastic syndromes and myeloproliferative disorders .

Pediatric leukaemia

Paediatric leukaemia is the most common cancer in children, accounting for up to 30% of all paediatric cancers. About 80% of all paediatric leukaemias are acute lymphoblastic leukaemias (ALL). It is most common in children aged 2 to 5 years, but it can occur at any age. ALL is also more common in boys than in girls, and the prognosis for boys is slightly worse. In total, 85% of paediatric ALL is B-precursor derived, with the remaining 15% being T-cell derived. ALL symptoms include prolonged fever, bone pain, swollen lymph nodes, petechiae, and dyspnoea due to mediastinum enlargement. ALL was primarily diagnosed based on the morphological identification of leukemic bone marrow blasts over 25%. In some cases, a repeat bone marrow examination may be required to confirm the diagnosis.

The typical treatment for pediatric Acute Lymphoblastic Leukaemia (ALL) involves:

• Induction therapy using steroids, vincristine, and asparaginase to achieve complete remission.
• Consolidation therapy follows to eliminate residual leukemic cells, often incorporating high-dose or escalating methotrexate. For high-risk cases, allogeneic stem cell transplantation may be considered.
• Maintenance therapy lasting 1-2 years with 6-mercaptopurine and weekly methotrexate following consolidation.
• CNS-directed therapy, previously consisted of cranial irradiation, and now uses intrathecal injection and high-dose methotrexate to reduce late complications.

Symptoms

The symptoms of leukaemia may be mild at first but later certain symptoms do occur like the following: Anaemia; Swollen lymph nodes; Bleeding from gums or in stool; Fatigue; Frequent infection; Excessive sweating; Bone tenderness; Sudden weight loss; Fever; Easy bruises; Seizures and headache (if it spreads to the central nervous system); Loss of muscle control; Enlarged liver or spleen.

Causes

The possible causes and risk factors for leukaemia vary between the different forms of the disease.

• Radiation exposure is one of the better-studied risk factors and includes radiation related to atomic bombs, nuclear accidents, medical radiation therapy, and radiation related to diagnostic procedures such as CT scans.
• Home and environmental exposures to chemicals such as benzene (found in paints, solvents, gasoline, and more) have also been linked with leukaemia.
• Smoking is a significant risk factor for AML, and leukaemia may be more common in children whose parents smoked during pregnancy.
• ALL is more common in children, especially those under age 5 years, while CLL and CML are more common in older adults.
• Infection with the human T-cell leukaemia virus (HTLV-1) is also a significant risk factor for leukaemia but is uncommon in the United States.
• Some medical conditions (such as myelodysplastic syndromes ) as well as previous chemotherapy increase risk.
• several possible risk factors are being investigated as well, such as certain dietary practices and radon exposure in the home.
• A family history of the disease increases the risk of CLL but appears to have little role in CML and ALL. Some genetic syndromes, such as Down syndrome and Fanconi Anaemia elevate risk as well.

Diagnosis

• There are several symptoms of leukaemia which are similar to other disorders.
• A proper medical examination is necessary.

The tests for diagnosing leukaemia are as follows:

• Complete blood count test: To determine the count of WBCs, RBCs and platelets in the bloodstream or the formation of any abnormal cells.
• Tissue biopsy scan: A test in which a small tissue is taken from the lymph nodes or bone marrow to identify the presence of leukaemia, its type and its growth rate.
• Genetic abnormality test: A test to determine the Philadelphia chromosome, a genetic defect present in leukaemia cells.
• Staging: This test helps determine the outlook of the patient based on the type of leukaemia.
• Cytochemistry: A test in which stains are used to identify the tissue structure of the bone marrow cells.
• Lumbar puncture: A test performed by the spinal fluid to identify the spread of the leukaemia to the central nervous system.
• Other methods of diagnosing include CT scan, MRI and ultrasound.

Treatment

The treatments include:

• Radiation therapy: Here, high-energy beams or X-rays are used to inhibit the growth of leukaemia cells.
• Chemotherapy: In this method, a single or combination of drugs are used to treat leukaemia.
• Targeted therapy: Here, specific drugs are used to control certain vulnerabilities of the leukaemia cells or to halt certain functions of the leukaemia cells which prevents its further growth.
• Stem cell transplant: A treatment in which diseased bone marrow is replaced with healthy bone marrow.
• Biological therapy: This treatment includes antibodies, cytokines and tumour vaccines which help the immune system to identify the cancerous cells and attack them.
• Other treatment method include: Blood or platelet transfusions; Antiviral or antibiotics medications; Vaccines against flu; Anti-nausea drugs; Immunoglobulins injections

Leukaemia vs. Lymphoma: What’s the Difference?

Leukaemia and lymphoma are types of blood cancer. It’s estimated that in 2016 in the United States, approximately

• 60000 people will be diagnosed with leukaemia
• 80000 people will be diagnosed with lymphoma. At R: Diagram showing the lymph nodes lymphoma most commonly develops in.

While the two cancers share certain symptoms, there are some differences in their origins, symptoms, and treatments.

• Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. In lymphoma, lymphocytes change and grow out of control.

There are two main types of lymphoma:

1. Non-Hodgkin: Most people with lymphoma have this type.
2. Hodgkin

Non-Hodgkin and Hodgkin's lymphoma involves different types of lymphocyte cells.

• While the lymphatic tissue can be a primary site for cancer (e.g. lymphoma), it is more commonly a pathway for a metastatic process.
• The other major pathway for cancer spreading is through the bloodstream.